ES413960A1 - Procedimiento para la fabricacion de nuevos derivados de proilendiamina. - Google Patents
Procedimiento para la fabricacion de nuevos derivados de proilendiamina.Info
- Publication number
- ES413960A1 ES413960A1 ES413960A ES413960A ES413960A1 ES 413960 A1 ES413960 A1 ES 413960A1 ES 413960 A ES413960 A ES 413960A ES 413960 A ES413960 A ES 413960A ES 413960 A1 ES413960 A1 ES 413960A1
- Authority
- ES
- Spain
- Prior art keywords
- formula
- hydrogen
- compound
- manufacture
- represents hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- AOHJOMMDDJHIJH-UHFFFAOYSA-N propylenediamine Chemical class CC(N)CN AOHJOMMDDJHIJH-UHFFFAOYSA-N 0.000 title abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 6
- 239000001257 hydrogen Substances 0.000 abstract 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 230000005494 condensation Effects 0.000 abstract 2
- 238000009833 condensation Methods 0.000 abstract 2
- 239000003960 organic solvent Substances 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/36—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HUCI1228A HU164883B (fr) | 1972-04-24 | 1972-04-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES413960A1 true ES413960A1 (es) | 1976-05-01 |
Family
ID=10994437
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES413960A Expired ES413960A1 (es) | 1972-04-24 | 1973-04-21 | Procedimiento para la fabricacion de nuevos derivados de proilendiamina. |
| ES440575A Expired ES440575A1 (es) | 1972-04-24 | 1975-08-29 | Metodo para la fabricacion de nuevos derivados de propilen- diamina. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES440575A Expired ES440575A1 (es) | 1972-04-24 | 1975-08-29 | Metodo para la fabricacion de nuevos derivados de propilen- diamina. |
Country Status (13)
| Country | Link |
|---|---|
| JP (2) | JPS5842182B2 (fr) |
| AT (1) | AT324299B (fr) |
| CH (3) | CH580054A5 (fr) |
| CS (1) | CS203057B2 (fr) |
| DE (1) | DE2320058C2 (fr) |
| ES (2) | ES413960A1 (fr) |
| FR (1) | FR2183006A1 (fr) |
| HU (1) | HU164883B (fr) |
| NL (1) | NL7305696A (fr) |
| NO (1) | NO137548C (fr) |
| SE (1) | SE413022B (fr) |
| SU (4) | SU1014468A3 (fr) |
| YU (3) | YU110873A (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS51151972A (en) * | 1975-06-20 | 1976-12-27 | Matsushita Electric Ind Co Ltd | Conveyor means |
| IT1150959B (it) * | 1980-06-10 | 1986-12-17 | Simes | Sostanze datate di attivita' antispastica vasale e procedimenti per la loro preparazione |
| IT1156601B (it) * | 1982-05-13 | 1987-02-04 | Gd Spa | Dispositivo per la trasformazione di un moto rotatorio continuo di un albero conduttore in un moto arotatorio intermittente di un albero condotto |
| JPS60172762A (ja) * | 1984-02-17 | 1985-09-06 | Kyoei Giken:Kk | カム装置 |
| JPH0522497Y2 (fr) * | 1987-12-12 | 1993-06-10 | ||
| US7511077B2 (en) | 2005-02-09 | 2009-03-31 | Neuromed Pharmaceuticals Ltd. | Diamine calcium channel blockers |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1768297B1 (de) * | 1968-04-26 | 1971-12-16 | Beiersdorf Ag | Substituierte Alkylendiamine und deren Salze |
-
1972
- 1972-04-24 HU HUCI1228A patent/HU164883B/hu unknown
-
1973
- 1973-04-17 SE SE7305485A patent/SE413022B/xx unknown
- 1973-04-17 NO NO1625/73A patent/NO137548C/no unknown
- 1973-04-18 AT AT343773A patent/AT324299B/de not_active IP Right Cessation
- 1973-04-19 CH CH565573A patent/CH580054A5/xx not_active IP Right Cessation
- 1973-04-19 CH CH290576A patent/CH597146A5/xx not_active IP Right Cessation
- 1973-04-19 CH CH290676A patent/CH594595A5/xx not_active IP Right Cessation
- 1973-04-19 DE DE2320058A patent/DE2320058C2/de not_active Expired
- 1973-04-21 ES ES413960A patent/ES413960A1/es not_active Expired
- 1973-04-24 SU SU731914707A patent/SU1014468A3/ru active
- 1973-04-24 YU YU01108/73A patent/YU110873A/xx unknown
- 1973-04-24 NL NL7305696A patent/NL7305696A/xx not_active Application Discontinuation
- 1973-04-24 JP JP48046586A patent/JPS5842182B2/ja not_active Expired
- 1973-04-24 FR FR7314790A patent/FR2183006A1/fr active Granted
- 1973-04-24 CS CS732947A patent/CS203057B2/cs unknown
-
1974
- 1974-09-02 SU SU7402056645A patent/SU576040A3/ru active
- 1974-09-02 SU SU7402058045A patent/SU564805A3/ru active
- 1974-09-02 SU SU7402058046A patent/SU576915A3/ru active
-
1975
- 1975-08-29 ES ES440575A patent/ES440575A1/es not_active Expired
-
1980
- 1980-01-04 YU YU00020/80A patent/YU2080A/xx unknown
- 1980-01-04 YU YU00019/80A patent/YU1980A/xx unknown
-
1982
- 1982-06-16 JP JP57103673A patent/JPS5838237A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| YU1980A (en) | 1983-02-28 |
| HU164883B (fr) | 1974-05-28 |
| SU1014468A3 (ru) | 1983-04-23 |
| NO137548B (no) | 1977-12-05 |
| FR2183006A1 (en) | 1973-12-14 |
| NO137548C (no) | 1978-03-15 |
| ES440575A1 (es) | 1977-03-01 |
| NL7305696A (fr) | 1973-10-26 |
| FR2183006B1 (fr) | 1976-09-03 |
| YU110873A (en) | 1982-02-28 |
| SE413022B (sv) | 1980-03-31 |
| SU576915A3 (ru) | 1977-10-15 |
| SE7305485L (fr) | 1973-10-25 |
| DE2320058A1 (de) | 1973-11-08 |
| DE2320058C2 (de) | 1982-11-18 |
| CS203057B2 (en) | 1981-02-27 |
| JPS5842182B2 (ja) | 1983-09-17 |
| AT324299B (de) | 1975-08-25 |
| SU564805A3 (ru) | 1977-07-05 |
| SU576040A3 (ru) | 1977-10-05 |
| CH594595A5 (fr) | 1978-01-13 |
| CH580054A5 (fr) | 1976-09-30 |
| JPS5838237A (ja) | 1983-03-05 |
| YU2080A (en) | 1983-02-28 |
| CH597146A5 (fr) | 1978-03-31 |
| JPS4947354A (fr) | 1974-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES394421A1 (es) | Procedimiento para la produccion de derivados de fenil-imi-dazolilalcalino. | |
| ES413960A1 (es) | Procedimiento para la fabricacion de nuevos derivados de proilendiamina. | |
| ES457993A1 (es) | Un procedimiento para la preparacion de una isotiazolopiri- dina. | |
| ES385628A1 (es) | Procedimiento para la obtencion de derivados de morfolina ypiperazina. | |
| ES411038A1 (es) | Un procedimiento para la preparacion de compuestos semisin-teticos intermedios en la produccion de cefalosporinas, pe- nicilinas y antibioticos relacionados de beta-lactama. | |
| ES404745A1 (es) | Un procedimiento para preparar cefalosporinas. | |
| GB1029228A (en) | A method of preparing new quaternary ammonium salts with disinfectant activity | |
| ES404744A1 (es) | Un procedimiento para producir derivados de cefalosporina. | |
| ES433132A1 (es) | Procedimiento para la obtencion de derivados de 1-fenoxi-3- amino-propan-2-ol. | |
| ES394894A1 (es) | Procedimiento para la obtencion de acidos fenilacetohidro- xamicos. | |
| ES424272A1 (es) | Un procedimiento para preparar n - (2 - amino - 3,5 - di- bromobencil) - n - metilciclohexilamina terapeuticamente va-liosa. | |
| ES395958A1 (es) | Un procedimiento para la produccion de un parahidroxifenil -alfa- aminoacido. | |
| ES429691A1 (es) | Proceso para la preparacion del acido p. isobutil-hidratro-pico. | |
| ES362369A1 (es) | Procedimiento para la preparacion de nuevos derivados de piperidina. | |
| ES387410A1 (es) | Un procedimiento de preparacion de nuevas sales de mono- esteres de piridoxina. | |
| FR2322141A1 (fr) | Procede de production d'oxazolidines n-substituees | |
| ES398973A1 (es) | Procedimiento para la obtencion de un derivado de rifamici-na sv. | |
| ES441029A1 (es) | Procedimiento de preparacion de un nuevo derivado del acido acetilsalicilico. | |
| ES414340A1 (es) | Procedimiento de preparacion de derivados de la n-(m-tri- fluormetiltio-fenil-)-piperazina. | |
| ES360859A1 (es) | Procedimiento para la preparacion de nuevos derivados de tiazepina. | |
| ES386716A1 (es) | Procedimiento para la preparacion de nuevos derivados de tiepina. | |
| ES390235A1 (es) | Procedimiento para la preparacion de derivados de penicili-na. | |
| ES402955A1 (es) | Procedimiento para la obtencion del 4-acetamido-fenil 2-a- cetoxi-benzoato. | |
| ES454326A1 (es) | Un procedimiento para la preparacion de nuevos derivados de cumarina. | |
| ES426874A1 (es) | Procedimiento para la obtencion de nuevos derivados de dia-zepina. |